Peter T Slover insider trades

Open-market stock purchases and sales by Peter T Slover, Chief Financial Officer at Contineum Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2010.

Recent trades

DateStockTradeValue
Jan 30, 2026CTNM Contineum Therapeutics, IncBought (not open market)—

Companies traded

  • CTNM Contineum Therapeutics, Inc: other filings, last Jan 30, 2026
  • SPHS Sophiris BIO Inc: 1 buy, last Dec 19, 2019
  • ANDS Anadys Pharmaceuticals Inc: other filings, last Jan 20, 2011

Get free alerts when Peter T Slover files a new trade →